No clinically relevant removal of meropenem by cytokine adsorber CytoSorb® in critically ill patients with sepsis or septic shock
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1238
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
No clinically relevant removal of meropenem by cytokine adsorber CytoSorb® in critically ill patients with sepsis or septic shock ; volume:47 ; number:11 ; day:14 ; month:9 ; year:2021 ; pages:1332-1333 ; date:11.2021
Intensive care medicine ; 47, Heft 11 (14.9.2021), 1332-1333, 11.2021
- Urheber
-
Liebchen, Uwe
Scharf, Christina
Zoller, Michael
Weinelt, Ferdinand
Kloft, Charlotte
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00134-021-06487-y
- URN
-
urn:nbn:de:101:1-2022011519243150262933
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liebchen, Uwe
- Scharf, Christina
- Zoller, Michael
- Weinelt, Ferdinand
- Kloft, Charlotte
- SpringerLink (Online service)
Ähnliche Objekte (12)
Hemoadsorption by CytoSorb in septic patients: a case series
Hemoadsorption with CytoSorb® and the early course of linezolid plasma concentration during septic shock
Efficacy of CytoSorb®: a systematic review and meta-analysis
Analyse der Ulmer Datenbanken zum internationalen CytoSorb-Register: Dynamik der laborchemischen Leberparameter unter Anwendung des Hämadsorbers CytoSorb bei Patienten der herzchirurgischen Intensivstation
Datenerhebung und Auswertung zum internationalen CytoSorb-Register am Universitätsklinikum Ulm
Prospektive Observationsstudie zur Anwendung von CytoSorb® bei Intensivpatienten mit akutem Leberversagen
Opportunities, controversies and challenges of extracorporeal hemoadsorption with CytoSorb® during ECMO
Does the cytokine adsorber CytoSorb® reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational study
Potential correlation between hemodynamic improvement and an immune-modulation effect in pediatric patients with septic shock treated with renal replacement therapy and CytoSorb®: an insight from the PedCyto study
Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial
Hemoadsorption in the critically ill - final results of the International CytoSorb Registry
Improved Survival beyond 28 Days up to 1 Year after CytoSorb Treatment for Refractory Septic Shock: A Propensity-Weighted Retrospective Survival Analysis
Hemoadsorption by CytoSorb in septic patients: a case series
Hemoadsorption with CytoSorb® and the early course of linezolid plasma concentration during septic shock
Efficacy of CytoSorb®: a systematic review and meta-analysis
Analyse der Ulmer Datenbanken zum internationalen CytoSorb-Register: Dynamik der laborchemischen Leberparameter unter Anwendung des Hämadsorbers CytoSorb bei Patienten der herzchirurgischen Intensivstation
Datenerhebung und Auswertung zum internationalen CytoSorb-Register am Universitätsklinikum Ulm
Prospektive Observationsstudie zur Anwendung von CytoSorb® bei Intensivpatienten mit akutem Leberversagen
Opportunities, controversies and challenges of extracorporeal hemoadsorption with CytoSorb® during ECMO
Does the cytokine adsorber CytoSorb® reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational study
Potential correlation between hemodynamic improvement and an immune-modulation effect in pediatric patients with septic shock treated with renal replacement therapy and CytoSorb®: an insight from the PedCyto study
Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial
Hemoadsorption in the critically ill - final results of the International CytoSorb Registry
Improved Survival beyond 28 Days up to 1 Year after CytoSorb Treatment for Refractory Septic Shock: A Propensity-Weighted Retrospective Survival Analysis
Hemoadsorption by CytoSorb in septic patients: a case series
Hemoadsorption with CytoSorb® and the early course of linezolid plasma concentration during septic shock
Efficacy of CytoSorb®: a systematic review and meta-analysis
Analyse der Ulmer Datenbanken zum internationalen CytoSorb-Register: Dynamik der laborchemischen Leberparameter unter Anwendung des Hämadsorbers CytoSorb bei Patienten der herzchirurgischen Intensivstation
Datenerhebung und Auswertung zum internationalen CytoSorb-Register am Universitätsklinikum Ulm
Prospektive Observationsstudie zur Anwendung von CytoSorb® bei Intensivpatienten mit akutem Leberversagen
Opportunities, controversies and challenges of extracorporeal hemoadsorption with CytoSorb® during ECMO
Does the cytokine adsorber CytoSorb® reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational study
Potential correlation between hemodynamic improvement and an immune-modulation effect in pediatric patients with septic shock treated with renal replacement therapy and CytoSorb®: an insight from the PedCyto study
Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial
Hemoadsorption in the critically ill - final results of the International CytoSorb Registry